← All organizations

Goldman, Butterwick, Fitzpatrick and Groff

Academic/Hospital

Also known as: DCLA | Goldman, Butterwick, Fitzpatrick and Groff

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Sep 27, 2024

Timeline

No events for the selected filters.

Drugs by trial phase (10 distinct, 10 trials)

Phase 4 (5 own, 0 via acquisition)

Phase 3 (1 own, 0 via acquisition)

vitamin c

Phase 2 (1 own, 0 via acquisition)

sodium tetradecyl sulfate

Other trials (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (12)

NCT06603857Lead sponsorPhase 2/Phase 3Sep 27, 2024
NCT05597995Lead sponsorPhase 2Nov 1, 2022
NCT05359419Lead sponsorPhase 4May 15, 2022
NCT04096742Lead sponsorPhase 4Oct 28, 2019
NCT03750422Reponsible party - principal investigatorN/AJul 1, 2018
NCT03750422Lead sponsorN/AJul 1, 2018
NCT03361176Lead sponsorPhase 4Dec 31, 2017
NCT03241563Overall official - principal investigatorPhase 4Apr 30, 2016
NCT03241563Lead sponsorPhase 4Apr 30, 2016
NCT02454088Lead sponsorN/AMay 31, 2015
NCT02451579Lead sponsorN/AFeb 1, 2015
NCT02446223Lead sponsorPhase 4Jan 1, 2015

Details

Last known activity: Sep 27, 2024